Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Vox Sanguinis|November 19, 2020
Costs associated with transfusion therapy in patients with myelodysplastic syndromes in Sweden: a nationwide retrospective cohort studyJingcheng Zhao, Torsten Dahlén, Gustaf EdgrenTransfusion|August 21, 2020
Risk of hematological malignancy in blood donors: A nationwide cohort studyJingcheng Zhao, Torsten Dahlén, Anne Brynolf, et al.Journal of Internal Medicine|November 14, 2022
A population-based, retrospective cohort study of the association between ABO blood group and risk of COVID-19Torsten Dahlén, Huiqi Li, Fredrik Nyberg, et al.The Lancet. Digital Health|January 26, 2024
Using routine health-care data to search for unknown transfusion-transmitted disease: a nationwide, agnostic retrospective cohort studyTorsten Dahlén, Jingcheng Zhao, Michael P Busch, et al.Plos Computational Biology|June 9, 2020
Measurable health effects associated with the daylight saving time shiftHanxin Zhang, Torsten Dahlén, Atif Khan, et al.Elife|April 27, 2021
An agnostic study of associations between ABO and RhD blood group and phenome-wide disease riskTorsten Dahlén, Mark Clements, Jingcheng Zhao, et al.European Journal of Haematology|April 17, 2015
Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromesTorsten Dahlén, Mats Kalin, Kerstin Cederlund, et al.Journal of Internal Medicine|July 21, 2021
The frequency of misattributed paternity in Sweden is low and decreasing: A nationwide cohort studyTorsten Dahlén, Jingcheng Zhao, Patrik K E Magnusson, et al.Transfusion|April 10, 2025
An agnostic study of donor and component factors associated with transfusion-related changes in laboratory markersLucas D Ekström, Mark Clements, Nareg Roubinian, et al.European Journal of Haematology|November 6, 2024
Loss in Overall and Quality-Adjusted Life Expectancy for Patients With Chronic-Phase Chronic Myeloid LeukemiaEnoch Yi-Tung Chen, Torsten Dahlén, Leif Stenke, et al.Pageof 2